Clinical Trial

Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated April 10, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this randomized, open-label, active-controlled, parallel-group, multicenter, phase IV study is to assess the efficacy and safety of Fang Le Shu versus Guo Na Fen used for controlled ovarian stimulation in infertile women undergoing In Vitro Fertilization-Embryo Transfer.
Trial Details
NCT Number NCT06921395
Lead Sponsor LG Chem
Conditions Female Infertility
Enrollment 248 participants
Start Date 2025-02-15
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-10